Emilia Liana Falcone joins the IRCM

May 3 2018 | Appointment, Rare diseases

All news

Tarik Möröy, President and Scientific Director of the Montreal Clinical Research Institute (IRCM), is pleased to announce the appointment of Emilia Liana Falcone as Director of the new Microbiome and Mucosal Defence Research Unit and Assistant Research Professor.
Dr. Falcone's research unit will be part of the IRCM's Immunity and Viral Infections Research Division. As a physician, she will also collaborate with the Primary Immunodeficiency Clinic, within the Institute’s Research Centre on Rare and Genetic Diseases in Adults. Emilia Liana Falcone will also practise medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and will be an Assistant Clinical Professor in the Department of Medicine of Université de Montréal’s Faculty of Medicine. This appointment is effective September 1, 2018.
The intestinal microbiota refers to all the microorganisms within the gastrointestinal tract. The human microbiota is formed of approximately 100,000 billion bacteria, representing a total weight of around 2 kg. It is only recently that the scientific community has uncovered how the microbiota can affect health, especially the immune system.
“The IRCM is privileged to welcome a researcher with such a remarkable track record as Dr. Falcone,” said Tarik Möröy, President and Scientific Director of the IRCM. “Thanks to her expertise, the Institute will be able to build on the rapidly expanding field of microbiome research, both in the laboratory and in clinical settings.”
“I am very pleased with the appointment of Dr. Falcone,” said Yves Berthiaume, Vice President, Clinic and Clinical Research, at the IRCM. “Her knowledge and experience will be a definite asset for the IRCM Clinic as well as for its Research Centre on Rare and Genetic Diseases in Adults.”
Emilia Liana Falcone studied medicine at McGill University. She obtained a specialization in internal medicine at Tufts Medical Center in Boston, as well as a specialization in infectious diseases at the National Institute of Health in Bethesda, Maryland. She recently completed her Ph.D. at the University of Cambridge, in England, during which she studied the role of the microbiome in chronic granulomatous disease, a disease that causes severe immune deficiencies. She is the author of several scientific publications and has received numerous awards for excellence.